RecruitingChemotherapy-induced Peripheral NeuropathyQuality of Life
International CIPN Assessment and Validation Study
Eligible age
18+ yrs
Accepts
All genders
Locations
8 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.
Sponsor: University of Milano Bicocca
You may qualify if…
- ✓ Subjects must meet all of the following inclusion criteria to be eligible for enrolment into the study:
- ✓ 1. Subjects must be candidates for neurotoxic chemotherapy at doses expected to be potentially neurotoxic (a list of neurotoxic drugs is provided in Appendix 1).
- ✓ 2. Male and female subjects who are 18 years of age or older.
- ✓ 3. Subjects freely provide informed consent by signing and dating an informed consent form prior to study entry.
- ✓ 4. Subjects must be willing to complete all study-related activities and follow-up visits required by the protocol.
- ✓ 5. Subjects must have a Karnofsky performance score greater than or equal to 70. Exclusion Criteria
- ✓ Subjects presenting with any of the following will not be included in the study:
- ✓ 1. Poor prognosis, with high probability to be unable to complete the planned chemotherapy treatment.
Where it's recruiting
Source: ClinicalTrials.gov · NCT04633655 · last updated 2025-07-25